Breast Cancer Index® and new data on its power to predict extended endocrine therapy benefit presented at ASCO 2019
June 03, 2019 08:00 ET
|
Biotheranostics, Inc.
San Diego, CA, June 03, 2019 (GLOBE NEWSWIRE) -- Biotheranostics, Inc. announces new pivotal data on the Breast Cancer Index® (BCI) being presented at the ASCO conference June 3, 2019 that further...
Genomic Profiling Study Brings Personalized Medicine to Metastatic Bladder Cancer Patients
September 24, 2015 08:13 ET
|
Bladder Cancer Advocacy Network
BETHESDA, Md., Sept. 24, 2015 (GLOBE NEWSWIRE) -- The Bladder Cancer Advocacy Network (BCAN) and Paradigm today announced a partnership for the launch of a large-scale genomically-driven bladder...